Avelient BioPharm Blog

Comments (0)

Obesity and Our Bacterial Friends

One of the persistent arguments in today’s world is whether obesity is in our genes or something that can be controlled by diet and exercise (and a good night’s sleep and low stress and …).  On my way drive home from work last week, I heard a very interesting story on NPR about research on the [...]

Are your Political Views Biologically Programmed?

I was sitting down for a drink the other day with a longtime friend when the topic of politics came up for discussion.  Growing up in Massachusetts, I rarely encountered somebody of a conservative mindset, let alone someone who would admit to being so in such a heavily democratic state, so I had always assumed [...]

Compassionate Use for Investigational Drugs

In the Avelient BioPharm Blog article “A Brief FDA History Lesson“, Mariano Di Fabio provided some background on the events that lead to the establishment of the FDA’s current clinical trial framework, and he questioned if this framework should be changed so that experimental drugs could be released for use by terminally ill patients.  Mariano [...]

Latest Tactics to Stifle Generic Competition

In the last half of this decade, it is estimated that $100 billion worth of brand name drugs have lost (or will lose) patent exclusivity. Each year, generic drugs take more and more of the market share from brand-name drug manufacturers.  In fact, the percentage of drug prescriptions dispensed for generics increased from 47% to [...]

Pharmaceutical Profile: Sequenom

I was reading my monthly copy of Pharmaceutical Executive magazine when I came across Joanna Breitstein’s excellent article profiling the latest trend in the pharmaceutical arena: big deals that are safe bets.  In her article, “Place your Bets,” Breitstein characterizes Roche’s bid to acquire Genentech as a reflection of the cautious approach to deal-making that [...]

The New War on Drugs: Vaccinations?

Ask yourself, when your child grows up, do you want him to be a cocaine addict? What if there was something you could do to prevent it? What if it was as easy as protecting your child against tetanus or the mumps?  We may not be far away from the first vaccine to fight against [...]

Back to Virtuality

It’s been a while since I last wrote on the blog, and for those of you that follow regularly, I apologize. We’ve had a lot going on in our company, and if you haven’t already heard, we re-designed our web site (go to www.avelient.com to see the new site) and released our first major [...]

Super Blog

This week seems to be a week for supers. The Superbowl was on Sunday, with the New York Giants defeating the near-perfect New England Patriots in a stunning upset and deserved victory. Today is Super Tuesday, and Democrats and Republicans are vying for the top candidacy spot in their respective parties. And [...]

Appreciating Happiness through Melancholy

I’m sitting here on my couch tonight, my nose red and sore, my lips chapped, my nose running, and my entire body feeling that familiar achy feeling that comes on as a virus takes control of my body and becomes a cold. I’m most certainly not at my happiest, and it shows, both in [...]

Bridging Solitary to Social Via Virtual Reality

It’s not often that 2 subjects that pique my interest converge so nicely into one article.
As you know from a number of posts on this blog, I’ve been writing extensively about my experiences in Second Life, and how pioneers in this virtual world are leveraging its unique characteristics to either further their educational mission or [...]